regulatory
confidence high
sentiment positive
materiality 0.60
Genprex regains compliance with Nasdaq minimum bid price requirement
Genprex, Inc.
- Nasdaq Panel notified Genprex on Aug 4, 2026 that it has regained compliance with the $1.00 minimum bid price rule.
- Company must maintain closing bid price at or above $1.00 each trading day until December 7, 2026.
- Panel retains jurisdiction; if non-compliant with any other rule, company has 7 days to propose a cure plan.
- Previously, on July 29, 2026, the Panel had granted an exception to demonstrate compliance.